February 5, 2023
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

MannKind’s revenues were way up in first quarter but so were net losses


Westlake Village-based biotech company MannKind grew its revenue 184 percent for its first quarter to $3.4 million, but net losses still mounted, reaching $30.4 million, nearly double its loss for the same period in 2017. The increase comes from sales of its inhalable insulin product Afrezza, and it adopted a new accounting standard to measure…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.